Artrya Signs First U.S. Hospital Clinical Partnership

Significant market entry step into the USA, which represents 42% of the global healthcare market Clinical Advisory Board composition completed with the appointment of Dr John (Jack) Lewin PERTH, AUSTRALIA., (May 9, 2022)–Artrya Limited (ASX: AYA, Artrya or the Company), creator of the AI- based cardiac software solution Artrya Salix, today announced its first U.S. clinical partnership with Alabama